Alcon Secures FDA Approval for TRYPTYR (Acoltremon Ophthalmic Solution) 0.003% for Dry Eye Disease
TRYPTYR, the first TRPM8-targeting eye drop, improves tear production from Day 1 in dry eye patients. Alcon (Geneva, Switzerland) has…
A Global Crisis in Basic Eye Care: Millions Still Struggling Without Glasses
Global access to eye glasses is at 65.8%—barely up since 2010 and far below WHO’s 2030 goal. A new study…
latest posts
![[Cooper Vision] WCO Navigator KOL interview Thumbnail (2) (1)](https://cookiemagazine.org/wp-content/uploads/sites/6/2024/11/Cooper-Vision-WCO-Navigator-KOL-interview-Thumbnail-2-1-579x326.png)
![shutterstock_1891488811 [Converted] 01](https://cookiemagazine.org/wp-content/uploads/sites/6/2024/08/shutterstock_1891488811-Converted-01-579x326.png)
![shutterstock_370294769 [Converted]_V2](https://cookiemagazine.org/wp-content/uploads/sites/6/2023/09/shutterstock_370294769-Converted_V2-579x326.jpg)
